α-Glucosidase-IN-29

• UNSPSC Description:

  α-Glucosidase-IN-29 (compound 19) is a α-glucosidases inhibitor (IC50=1.21 μM, Ki=1.80 μM). α-Glucosidase-IN-29 ca be used for research of diabetes and related diseases[1].

• Target Antigen:

  Glycosidase

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/α-glucosidase-in-29.html

• Solubility:

  10 mM in DMSO

• Smiles:

  OC(C1=CC=CC=C1O2)=C(C(C3=CC(Br)=C(OCCCCCCCC)C(Br)=C3)C4=C(O)C(C=CC=C5)=C5OC4=O)C2=O

• Molecular Weight:

  698.40

• References & Citations:

  [1]Phan TH, et al. Designing Potent 伪-Glucosidase Inhibitors: A Synthesis and QSAR Modeling Approach for Biscoumarin Derivatives. ACS Omega. 2023 Jul 11;8(29):26340-26350.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2949513-11-3